Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

NCT06712355 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

621

Enrollment

INDUSTRY

Sponsor class

Conditions

Extensive-stage Small-cell Lung Cancer

Interventions

DRUG: Pumitamig
DRUG: Atezolizumab
DRUG: Etoposide
DRUG: Carboplatin (or cisplatin if carboplatin is not tolerated)

Sponsor

BioNTech SE

Collaborators

[object Object]